Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial - de Vries, Rory D; Altenburg, Arwen F; Nieuwkoop, Nella J; de Bruin, Erwin; van Trierum, Stella E; Pronk, Mark R; Lamers, Mart M; Richard, Mathilde; Nieuwenhuijse, David F; Koopmans, Marion P G; Kreijtz, Joost H C M; Fouchier, Ron A M; et al. (The Journal of infectious diseases, 2018)
Keywords: Adult; Antibodies, Viral - blood; Antibody-Dependent Cell Cytotoxicity; Cross Reactions; Double-Blind Method; Drug Carriers; Female; Hemagglutination Inhibition Tests; Hemagglutinin Glycoproteins, Influenza Virus - genetics; Hemagglutinin Glycoproteins, Influenza Virus - immunology; Humans; Immunization Schedule; Influenza A Virus, H5N1 Subtype - genetics; Influenza A Virus, H5N1 Subtype - immunology; Influenza Vaccines - administration & dosage; Influenza Vaccines - genetics; Influenza Vaccines - immunology; Influenza, Human - prevention & control; Major and Brief Reports; Male; Neutralization Tests; Protein Array Analysis; T-Lymphocytes - immunology; Vaccines, Synthetic - administration & dosage; Vaccines, Synthetic - genetics; Vaccines, Synthetic - immunology; Vaccinia virus - genetics; Young Adult